Left Menu
Development News Edition

Researchers find new potential treatment for prion diseases

A possible effective treatment strategy for patients suffering from prion disease, has been suggested by a novel study published by the Oxford University Press.

ANI | Washington DC | Updated: 10-08-2020 11:50 IST | Created: 10-08-2020 11:40 IST
Researchers find new potential treatment for prion diseases
Representative image. Image Credit: ANI

A possible effective treatment strategy for patients suffering from prion disease, has been suggested by a novel study published by the Oxford University Press. The result of the new study was published in the journal Nucleic Acids Research. Prion disease is a rapidly fatal and currently untreatable neurodegenerative disease. While prion disease is quite rare, it typically causes rapid neurodegeneration. About 300 cases of prion diseases are reported each year in the United States.

The most common form of prion disease that affects humans is Creutzfeldt-Jakob disease. Bovine spongiform encephalopathy, popularly known as Mad Cow Disease, is another prion disease. Prion diseases are caused by disrupting the structure of a normal human prion protein, producing toxic clumps in the brain. Because prion protein is central to disease, reducing levels of prion protein in patients is a promising therapeutic approach. Senior author Sonia Vallabh learned that she carried a mutant form of the prion protein gene prior to switching careers to become a patient-scientist and advocate for treatment. She and her coworkers had previously observed that antisense oligonucleotides that reduce levels of the prion protein can extend the survival of animals infected with misfolded prions. While these initial data were promising, many critical questions remained before therapeutic development could be possible.

Research teams led by Vallabh at the Broad Institute of Harvard and MIT, Holly Kordasiewicz at Ionis Pharmaceuticals, and Deb Cabin at McLaughlin Research Institute, report the results of preclinical studies of an antisense therapy against prion disease. In this new work, using an expanded set of prion protein -targeting antisense oligonucleotides, the authors have laid the basis for full-scale clinical development. This research shows that, across multiple treatment paradigms, reducing levels of prion protein in prion-infected lab animals significantly extend their survival. Researchers here showed that reducing levels of the prion protein can triple the survival of prion-infected animals. Even reducing prion protein levels by a small amount, which should be easier to achieve clinically, resulted in significant survival benefits.

Reduction of prion protein is effective across prion strains and across a battery of different treatment time points. The researchers show that reducing prion protein is effective before any symptoms are seen. They also demonstrate, for the first time, that a single dose of a prion protein -lowering treatment can reverse markers of disease even after toxic clumps have formed in the brain. "While there are still many steps ahead," said Vallabh, "these data give us optimism that by aiming straight at the genetic heart of prion disease, genetically targeted drugs designed to lower prion protein levels in the brain may prove effective in the clinic." (ANI)



Post-COVID-19 Nigeria needs a robust Health Management Information System to handle high disease burden

Nigeria is among a few countries that conceptualised a health management information system HMIS in the early 90s but implementation has been a challenge till date. Besides COVID-19, the country has a huge burden of communicable and non-com...

Morocco COVID-19 response: A fragile health system and the deteriorating situation

Learning from its European neighbors, Morocco imposed drastic measures from the initial stages of the COVID-19 outbreak to try to contain its spread. The strategy worked for a few months but the cases have surged after mid-June. In this sit...

COVID-19: Argentina’s health system inefficiencies exaggerate flaws of health information system

You can recover from a drop in the GDP, but you cant recover from death, was the straightforward mindset of Argentinas President Alberto Fernndez and defined the countrys response to COVID-19. The South American nation imposed a strict...

Rwanda’s COVID-19 response commendable but health information system needs improvement

Rwanda is consistently working to improve its health information system from many years. However, it is primarily dependent on the collection and reporting of health data on a monthly basis. Besides, evaluation studies on Rwandas HIS publis...


Latest News

Over 10,000 appeals pending in Delhi HC, but CBI preferring 2G appeal only: Adv Vijay Aggarwal argued

Opposing the Central Bureau of Investigation CBI and Enforcement Directorate ED application for early hearing in the 2G appeal against acquittal, Advocate Vijay Aggarwal representing businessman Shahid Balwa on Tuesday argued that more than...

Delhi govt releases Rs 32.1 crore grant-in-aid to DU's 6 colleges

The AAP government on Tuesday released a grant-in-aid of Rs 32.1 crore to six Delhi University colleges fully funded by it to pay salaries to staffers. However, the Delhi University Teachers Association DUTA called the grants inadequate.The...

New COVID-19 rules could spell last orders for some British pubs

Some pubs and restaurants already reeling from the pandemic face ruin, owners warned on Tuesday, after British Prime Minister Boris Johnson ordered them to close early for the next six months to help curb rapidly rising COVID-19 infections....

India, China agree to refrain from unilaterally changing situation on ground, stop sending more troops to frontline

India and China, which held the sixth round of Senior Commanders meeting on Monday following border tensions in eastern Ladakh, have agreed to avoid misunderstandings and misjudgments, stop sending more troops to the frontline, refrain from...

Give Feedback